Editorial: Nonalcoholic fatty liver disease therapy: Exploring molecular mechanisms of well-defined composition from natural plants

dc.contributor.authorZhang, Wenji
dc.contributor.authorHuang, Menghao
dc.contributor.authorLiu, Runping
dc.contributor.departmentBiochemistry and Molecular Biology, School of Medicine
dc.date.accessioned2023-09-11T15:41:21Z
dc.date.available2023-09-11T15:41:21Z
dc.date.issued2022-09-20
dc.eprint.versionFinal published version
dc.identifier.citationZhang W, Huang M, Liu R. Editorial: Nonalcoholic fatty liver disease therapy: Exploring molecular mechanisms of well-defined composition from natural plants. Front Pharmacol. 2022;13:1006750. Published 2022 Sep 20. doi:10.3389/fphar.2022.1006750
dc.identifier.urihttps://hdl.handle.net/1805/35517
dc.language.isoen_US
dc.publisherFrontiers Media
dc.relation.isversionof10.3389/fphar.2022.1006750
dc.relation.journalFrontiers in Pharmacology
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourcePMC
dc.subjectNon-alcholic fatty liver disease
dc.subjectNatural plants
dc.subjectWell-defined composition
dc.subjectNon-alcoholic steatohepatitis
dc.titleEditorial: Nonalcoholic fatty liver disease therapy: Exploring molecular mechanisms of well-defined composition from natural plants
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
fphar-13-1006750.pdf
Size:
505.41 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: